Magrath George 4
4 · Ocuphire Pharma, Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4
Magrath George
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2024-03-18$1.96/sh+25,000$49,050→ 425,000 total
Footnotes (1)
- [F1]The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.90 to $1.99, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.